TheProfitWatch

RNXT - RenovoRx, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.13 0.19 (16.81%) 0.0 (0.0%) 0.02 (1.54%) 0.03 (2.33%) -0.05 (-4.42%) 0.19 (17.12%) 0.03 (2.33%) 0.03 (2.33%)

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.08
Diluted EPS:
-0.08
Basic P/E:
-16.5
Diluted P/E:
-16.5
RSI(14) 1m:
100.0
VWAP:
1.32
RVol:

Events

Period Kind Movement Occurred At

Related News